Cancer Family
Central Nervous System Neoplasm
CI-CAN-00000118Explore in graph →
Non-malignant1,345 active trials7 approved drugs177 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000118Explore in graph →
Clinical trials
5,058 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01345903 | Robotic-Assisted Surgery in Treating Patients With Spine Tumors | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 0 | Nov 9, 2012 | clinicaltrials |
| NCT01438021 | Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 0 | Nov 9, 2012 | clinicaltrials |
| Evaluation of Kidney Function in Children With Brain Tumors |
| withdrawn |
| N/A |
| 0 |
| Children's Healthcare of AtlantaOTHER |
| 1 |
| Sep 24, 2012 |
| clinicaltrials |
| NCT00632437 | Intraoperative Optical Imaging of Brain Function | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT01151748 | Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma | withdrawn | Phase 2 | 0 | Stanford UniversityOTHER | 1 | May 14, 2012 | clinicaltrials |
| NCT00985036 | Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients | withdrawn | — | 0 | Marquette General Health SystemOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT01189513 | SCH-900105 in Recurrent Glioblastoma | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 20, 2012 | clinicaltrials |
| NCT01441388 | A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors. | withdrawn | Phase 1 | 0 | PfizerINDUSTRY | 0 | Dec 20, 2011 | clinicaltrials |
| NCT00469534 | Minimized Time to Beam in Patients With High Grade Gliomas | withdrawn | N/A | 0 | Alberta Health servicesOTHER | 0 | Sep 22, 2011 | clinicaltrials |
| NCT00712062 | Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System Lymphoma | withdrawn | Phase 2 | 0 | University of FloridaOTHER | 0 | Sep 20, 2011 | clinicaltrials |
| NCT00053040 | Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas | withdrawn | Phase 1 / Phase 2 | 0 | Pediatric Brain Tumor ConsortiumNETWORK | 0 | Sep 24, 2010 | clinicaltrials |
| NCT00243490 | Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors | withdrawn | Phase 2 | 5 | National Taiwan University HospitalOTHER | 1 | Jan 12, 2010 | clinicaltrials |
| NCT00904852 | Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme | withdrawn | Phase 1 | 30 | Millennium Pharmaceuticals, Inc.INDUSTRY | 0 | May 20, 2009 | clinicaltrials |
| NCT00083447 | Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme | withdrawn | Phase 3 | 323 | Xenova BiomedixINDUSTRY | 2 | Jan 7, 2009 | clinicaltrials |
| NCT00226668 | XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema | withdrawn | Phase 3 | 120 | Celtic Pharma Development ServicesINDUSTRY | 2 | Jan 3, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Nov 9, 2012source: clinicaltrials